Why Feeding Eczema-Prone Infants Earlier May Protect Them — The Dual Allergen Exposure Hypothesis

Lead

"We delayed eggs and peanuts because we were worried about allergies." This advice was once standard guidance given to many parents. Today, however, the evidence points in the opposite direction.

The shift seems paradoxical at first. Its theoretical foundation is the Dual Allergen Exposure Hypothesis — a framework proposing that the condition of the skin plays a central role in whether food allergies develop at all.

Two Routes: Tolerance Through the Gut, Sensitization Through the Skin

In 2008, British immunologist Gideon Lack proposed a pivotal hypothesis about how food allergies develop [1].

The oral route (induces immune tolerance): When a food antigen is ingested through the digestive tract, the intestinal immune system learns that this substance is harmless — pushing toward tolerance.

The transcutaneous route (induces allergic sensitization): When the same antigen enters through damaged skin — skin with a compromised barrier — the immune system reads it as a dangerous foreign substance, priming an IgE-mediated allergic response.

In other words, eating a food can build tolerance, while that same food entering through the skin before eating can trigger sensitization. These two pathways coexist. This is the Dual Allergen Exposure Hypothesis [1].

What the LEAP Trial Demonstrated

The strongest evidence for this hypothesis came from the LEAP trial (Du Toit et al., 2015) [2].

640 high-risk infants aged 4–11 months — those with eczema or egg allergy — were randomized to early peanut consumption or avoidance. Allergy rates were compared at age five.

The result was clear. Across all participants, allergy developed in 3.2% of the early-consumption group versus 17.2% in the avoidance group — a reduction of about 81% [2]. Among the 530 infants whose skin-prick test was negative at enrollment, the figures were 1.9% versus 13.7% (about 86%), and among the 98 who were already skin-prick positive, 10.6% versus 35.3% — the effect held in both groups [2]. The LEAP-On trial (2016) further confirmed that the protective effect persisted even after peanut consumption was stopped at age five [3].

This trial put a direct challenge to the premise that withholding allergenic foods protects against allergy.

The Skin Barrier and Sensitization

A critical condition for the Dual Allergen Exposure Hypothesis is the state of the skin barrier. Loss-of-function variants in the filaggrin gene (FLG) are a major risk factor for atopic dermatitis [4], and a degraded barrier allows external antigens to penetrate more easily through the skin.

A study of 619 exclusively breastfed infants examined at three months of age (Flohr et al., 2014) found that infants with atopic dermatitis were about six times more likely to be sensitized to foods, and the association grew stronger with eczema severity [6]. Because these infants had not yet eaten the foods, the authors suggested that sensitization may occur through the skin. The observed tendency for infants with eczema to develop food allergies is consistent with this transcutaneous sensitization pathway.

The causal chain runs as follows: eczema (disrupted skin barrier) → transcutaneous entry of food antigens → IgE sensitization → food allergy. Breaking that chain means addressing the eczema promptly and establishing oral tolerance early — both matter.

Early Introduction in Practice — What to Consider

The practical implications of this hypothesis and the evidence behind it are:

• Treat eczema early: Repairing the skin barrier may prevent transcutaneous sensitization (connected to proactive eczema therapy).
• Avoid unnecessary delays in starting solids: Particularly for high-risk infants, there is no evidence that delaying introduction prevents allergy — and it may do the opposite. Japan's clinical guideline likewise advises against delaying the introduction of foods such as egg [7].
• Be cautious about acting alone: For infants with moderate-to-severe eczema or pre-existing allergies, discuss the method and timing of introduction with your pediatrician or an allergist before proceeding.

The EAT trial (Perkin et al., 2016) examined early introduction of multiple allergens from three months of age in a general infant population, but did not find the same strong effect seen in high-risk groups [5]. This suggests that the strategy may differ between high-risk infants and the general population.

Translating This to Action

• If starting solids in an infant with eczema: consult a pediatrician or allergist before introducing eggs, peanuts, or other common allergens.
• "Eczema means we shouldn't introduce yet" runs counter to current evidence: Clarify your approach with a physician.
• Skin care and food introduction are a linked strategy: Managing eczema while introducing allergens early is the approach most consistent with the Dual Allergen Exposure Hypothesis.
• Tracking eczema and food introduction together: Logging the course of eczema (onset, affected areas, skin-care routine) alongside the food introduction timeline in a parenting app gives you more useful information to share at clinic visits. These parallel records have direct clinical value.

Summary

The instinct to delay out of fear is understandable. But under the Dual Allergen Exposure Hypothesis — where skin sensitization can precede oral exposure — delay may work against you. What the LEAP trial and this theoretical framework together suggest is that combining eczema treatment with early oral introduction of allergens is a rational strategy for food allergy prevention. Research in this area continues to advance, and the best judgment at any given moment is built through a conversation with a specialist.

Related Articles

• 237 Infant Eczema, Seborrheic Dermatitis, and Atopic Dermatitis: Telling Them Apart — Where the series begins: skin-barrier breakdown as the starting point for allergy sensitization
• 239 Atopic Dermatitis: Proactive Therapy — Repairing and maintaining the skin barrier through evidence-based treatment
• 240 Food Allergy: First Symptoms and Emergency Response — Putting the hypothesis into practice: what to do when symptoms appear and how to approach early introduction

References

1. Lack G. Epidemiologic risks for food allergy. J Allergy Clin Immunol. 2008;121(6):1331–1336. doi:10.1016/j.jaci.2008.04.032. PMID: 18539191.
2. Du Toit G, Roberts G, Sayre PH, et al.; LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–813. doi:10.1056/NEJMoa1414850. PMID: 25705822.
3. Du Toit G, Sayre PH, Roberts G, et al. Effect of avoidance on peanut allergy after early peanut consumption. N Engl J Med. 2016;374(15):1435–1443. doi:10.1056/NEJMoa1514209. PMID: 26942922.
4. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–446. doi:10.1038/ng1767. PMID: 16550169.
5. Perkin MR, Logan K, Tseng A, et al.; EAT Study Team. Randomized trial of introduction of allergenic foods in breast-fed infants. N Engl J Med. 2016;374(18):1733–1743. doi:10.1056/NEJMoa1514210. PMID: 26943128.
6. Flohr C, Perkin M, Logan K, et al. Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants. J Invest Dermatol. 2014;134(2):345–350. doi:10.1038/jid.2013.298. PMID: 23867897.
7. Japanese Society of Pediatric Allergy and Clinical Immunology. Food Allergy Clinical Practice Guidelines 2021. Tokyo: Kyowa Kikaku; 2021.